» Articles » PMID: 1429198

Potentiation of the Vincristine Effect on P388 Mouse Leukemia Cells by a Newly Synthesized Dihydropyridine Analogue, PAK-200

Overview
Specialty Oncology
Date 1992 Sep 1
PMID 1429198
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

A newly synthesized dihydropyridine analogue, 2-[benzyl(phenyl)amino]ethyl 1,4-dihydro-2,6-dimethyl-5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorina n-2-yl)-1- (2-morpholinoethyl)-4-(3-nitrophenyl)-3-pyridinecarboxylate (PAK-200), at 1 microM completely reversed the resistance to vincristine in vincristine-resistant P388 mouse leukemia cells (P388/VCR), in vitro. PAK-200 at 2 microM inhibited the efflux of [3H]vincristine from P388/VCR and increased the accumulation of [3H]vincristine in P388/VCR to a level similar to that in P388 cells. P-Glycoprotein in membrane vesicles from P388/VCR cells was photolabeled with [3H]azidopine. The labeling was completely inhibited by 10 microM PAK-200. The calcium antagonistic activity of PAK-200 was about 1000 times lower than that of another dihydropyridine analogue, nicardipine. Experiments with P388 and P388/VCR-bearing mice showed that PAK-200 enhanced the effect of vincristine on both leukemia cells in vivo. These results suggest that PAK-200 interacts with P-glycoprotein and reverses drug resistance in P388 mouse leukemia cells in vitro, and that PAK-200 has an ability to potentiate the effect of vincristine on P388 mouse leukemia cells in vivo.

Citing Articles

Cardioprotective Effect against Ischemia-Reperfusion Injury of PAK-200, a Dihydropyridine Analog with an Inhibitory Effect on Cl but Not Ca Current.

Namekata I, Tamura M, Kase J, Hamaguchi S, Tanaka H Biomolecules. 2023; 13(12).

PMID: 38136589 PMC: 10741401. DOI: 10.3390/biom13121719.


Two new indole alkaloids, 2-(3,3-dimethylprop-1-ene)-costaclavine and 2-(3,3-dimethylprop-1-ene)-epicostaclavine, from the marine-derived fungus Aspergillus fumigatus.

Zhang D, Satake M, Fukuzawa S, Sugahara K, Niitsu A, Shirai T J Nat Med. 2011; 66(1):222-6.

PMID: 21792727 DOI: 10.1007/s11418-011-0565-3.

References
1.
Safa A, Glover C, Sewell J, MEYERS M, Biedler J, Felsted R . Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem. 1987; 262(16):7884-8. View

2.
Debenham P, Kartner N, Siminovitch L, Riordan J, Ling V . DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression. Mol Cell Biol. 1982; 2(8):881-9. PMC: 369875. DOI: 10.1128/mcb.2.8.881-889.1982. View

3.
Yoshimura A, Kuwazuru Y, Sumizawa T, Ikeda S, Ichikawa M, Usagawa T . Biosynthesis, processing and half-life of P-glycoprotein in a human multidrug-resistant KB cell. Biochim Biophys Acta. 1989; 992(3):307-14. DOI: 10.1016/0304-4165(89)90089-5. View

4.
Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

5.
Nakagawa M, Akiyama S, Yamaguchi T, Shiraishi N, Ogata J, Kuwano M . Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line. Cancer Res. 1986; 46(9):4453-7. View